Sponsor:
Boston VA Research Institute, Inc.
Code:
NCT05299749
Conditions
Schizophrenia
Auditory Hallucination
Treatment-resistant Schizophrenia
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Not accepted
Interventions
stg-rt-fMRI-Neurofeeback
sham-rt-fMRI-Neurofeedback
Brief summary:
Conditions
Schizophrenia
Auditory Hallucination
Treatment-resistant Schizophrenia
Study ID
NCT05299749
Start date
Mar 1, 2022
Status verified date
Sep, 2025
Completion date
Jun 30, 2026
Anticipated
Primary completion date
Jun 30, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Not accepted
Enrollment
104 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: stg-rt-fMRI
sham comparator: sham-rt-fMRI
Interventions
stg-rt-fMRI-Neurofeeback
sham-rt-fMRI-Neurofeedback
Primary outcome measure
Central contacts
Locations
Boston VA Healthcare System, Brockton
Recruiting
Brockton, Massachusetts, United States, 02301
Contacts
Sponsor
Boston VA Research Institute, Inc.
Last update posted
Sep 18, 2025
Last verified
Sep, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Boston VA Research Institute, Inc. on 2025-09-18.